UA31493U - Способ лечения остеопороза - Google Patents
Способ лечения остеопороза Download PDFInfo
- Publication number
- UA31493U UA31493U UAU200713989U UAU200713989U UA31493U UA 31493 U UA31493 U UA 31493U UA U200713989 U UAU200713989 U UA U200713989U UA U200713989 U UAU200713989 U UA U200713989U UA 31493 U UA31493 U UA 31493U
- Authority
- UA
- Ukraine
- Prior art keywords
- day
- frequency
- power
- duration
- treatment
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 230000003642 osteotropic effect Effects 0.000 claims abstract description 7
- 239000007921 spray Substances 0.000 claims abstract description 6
- 230000003203 everyday effect Effects 0.000 claims description 6
- 108010068072 salmon calcitonin Proteins 0.000 claims description 5
- LDVRMNJZLWXJPL-JKQNMTHDSA-N calcitonin (human synthetic) Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 LDVRMNJZLWXJPL-JKQNMTHDSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 210000002346 musculoskeletal system Anatomy 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 238000012876 topography Methods 0.000 claims 1
- 230000003137 locomotive effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000007838 tissue remodeling Effects 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010065687 Bone loss Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002617 bone density conservation agent Substances 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002182 neurohumoral effect Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ лечения остеопороза путем применения остеотропного препарата в сочетании с физиотерапевтическим воздействием на пораженные зоны опорно-двигательного аппарата включает назначение остеотропного препарата Миакальцик-спрей один раз в день на фоне физиотерапевтического воздействия диадинамической электронейростимуляцией на участок шеи, на паравертебральные зоны и на зону остистых отростков.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200713989U UA31493U (ru) | 2007-12-13 | 2007-12-13 | Способ лечения остеопороза |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200713989U UA31493U (ru) | 2007-12-13 | 2007-12-13 | Способ лечения остеопороза |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA31493U true UA31493U (ru) | 2008-04-10 |
Family
ID=39819536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200713989U UA31493U (ru) | 2007-12-13 | 2007-12-13 | Способ лечения остеопороза |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA31493U (ru) |
-
2007
- 2007-12-13 UA UAU200713989U patent/UA31493U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Therapeutic effectiveness of instrument-assisted soft tissue mobilization for soft tissue injury: mechanisms and practical application | |
| Jingushi et al. | Low-intensity pulsed ultrasound treatment for postoperative delayed union or nonunion of long bone fractures | |
| Taheri et al. | Effect of extracorporeal shock wave therapy on lower limb spasticity in stroke patients | |
| BRPI0414455A (pt) | métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins | |
| MX375532B (es) | Usos de inhibidores de dpp iv. | |
| EA201491460A1 (ru) | ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα | |
| ATE414522T1 (de) | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure | |
| ATE532523T1 (de) | Zoledronsäure zur prävention oder verminderung von sekundärfrakturen nach hüftfraktur | |
| Wei | Effect of manual therapy on musculoskeletal injury rehabilitation: pain modulation and range of motion restoration | |
| UA31493U (ru) | Способ лечения остеопороза | |
| Notarnicola et al. | Shockwave therapy in the management of complex regional pain syndrome in medial femoral condyle of the knee | |
| Aleksiev | A novel physical therapy method of treating myofascial pain due to muscle spasm and shortening | |
| Sankar et al. | 3D printed quick healing cast: the exoskeletal immobilizer | |
| EA201001097A1 (ru) | Фармацевтическая композиция для профилактики и лечения резорбции костной ткани различной этиологии | |
| RU2579630C1 (ru) | Способ лечения переломов у детей с замедленным сращением | |
| RU2527159C2 (ru) | Способ сопроводительного лечения при эндопротезировании крупных суставов | |
| Ghafoor et al. | Effectiveness of manual physical therapy in treatment of plantar fasciopathy | |
| BISTRICEANU et al. | SEVERE MUSCLE SKELETAL TRAUMA BY CAR ACCIDENT WITH UPPER BRACHIAL PLEXUS INJURY–FAVORABLE REHABILITATIVE EVOLUTION | |
| WO2006123279A3 (en) | Natural drugs containing calcium and phosphate and apparatus for iontophoretic treatment of osteoporosis | |
| Nada et al. | Pulsed electromagnetic field and extracorporeal shock wave in treatment of delayed or non-united tibial fracture, a comparative study | |
| Zhu et al. | Morphometry in the ovariectomized rat model of osteoporosis after continuous and intermittent vibration | |
| Kertzman | 20 years of Treatment of Bone Non-Unions and Delayed Unions with Shock Waves | |
| Smith | MANUAL THERAPY IN MUSCULOSKELETAL INJURY REHABILITATION: A PAIN-MODULATION APPROACH | |
| Klychkova et al. | Modern concepts of conservative treatment methods of clubfoot | |
| Suto et al. | Low-intensity pulsed ultrasound to repair insufficiency fractures occurring adjacent to osteonecrosis caused by long-term steroid administration |